Maryland House Bill 602 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 20 2021 - 25% progression, died in chamber
Action: 2021-03-24 - Withdrawn by Sponsor
Text: Latest bill text (Introduced) [PDF]

Requiring the Maryland Medical Assistance Program to establish reimbursement levels, rather than maximum reimbursement levels, for drug products for which there is a certain generic equivalent; requiring that certain minimum reimbursement levels be at least equal to the National Average Drug Acquisition Cost of the generic product plus the fee-for-service professional dispensing fee determined by the Maryland Department of Health in accordance with the most recent in-State cost-of-dispensing survey; etc.

Maryland Medical Assistance Program and Managed Care Organizations That Use Pharmacy Benefits Managers - Reimbursement Requirements

Del. Nicholaus Kipke [R]

Date	Chamber	Action
2021-03-24	House	Withdrawn by Sponsor
2021-01-21	House	Hearing 2/10 at 1:30 p.m.
2021-01-20	House	First Reading Health and Government Operations

HB602 (Carry Over) 2021-03-24 - Withdrawn by Sponsor
HB756 (Carry Over) 2020-02-06 - Hearing 2/27 at 1:00 p.m.

Chapter	Article	Section	Citation Type	Statute Text
Health - General	15	118	(n/a)	See Bill Text
Insurance	15	1632	(n/a)	See Bill Text

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB0602?ys=2021RS
Text	https://mgaleg.maryland.gov/2021RS/bills/hb/hb0602f.pdf
Supplement	https://mgaleg.maryland.gov/2021RS/votes_comm/hb0602_hgo.pdf